{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:48:56Z","timestamp":1772282936539,"version":"3.50.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 MH067234"],"award-info":[{"award-number":["R01 MH067234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NICHD","award":["P30 HD15052"],"award-info":[{"award-number":["P30 HD15052"]}]},{"name":"NIH","award":["2T32MH065215-11T32"],"award-info":[{"award-number":["2T32MH065215-11T32"]}]},{"name":"Vanderbilt Neuroscience Scholars Award"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.nbd.2013.11.001","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T01:31:07Z","timestamp":1384306267000},"page":"210-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The role of cannabinoid 1 receptor expressing interneurons in behavior"],"prefix":"10.1016","volume":"63","author":[{"given":"Jacquelyn A.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szatm\u00e1r","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krassimira A.","family":"Garbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Everheart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levente","family":"Gell\u00e9rt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1roly","family":"Mirnics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2013.11.001_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/jnp.9.1.1","article-title":"The role of serotonin in the pathophysiology and treatment of schizophrenia","volume":"9","author":"Abi-Dargham","year":"1997","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0010","doi-asserted-by":"crossref","first-page":"15481","DOI":"10.1523\/JNEUROSCI.3410-11.2011","article-title":"The fear circuit revisited: contributions of the basal amygdala nuclei to conditioned fear","volume":"31","author":"Amano","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0015","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia. A longitudinal study of Swedish conscripts","volume":"2","author":"Andreasson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2013.11.001_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0091-3057(01)00578-0","article-title":"Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters","volume":"70","author":"Arevalo","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.11.001_bb0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","article-title":"Causal association between cannabis and psychosis: examination of the evidence","volume":"184","author":"Arseneault","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0030","doi-asserted-by":"crossref","first-page":"9935","DOI":"10.1523\/JNEUROSCI.0958-06.2006","article-title":"Local interneurons regulate synaptic strength by retrograde release of endocannabinoids","volume":"26","author":"Beierlein","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0035","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2013.11.001_bb0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.psychres.2007.10.009","article-title":"Substance use in severe mental illness: self-medication and vulnerability factors","volume":"165","author":"Bizzarri","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.nbd.2013.11.001_bb0045","article-title":"Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms","author":"Bloomfield","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00213-004-1941-4","article-title":"The CB receptor agonist WIN 55,212-2 fails to elicit disruption of prepulse inhibition of the startle in Sprague\u2013Dawley rats","volume":"177","author":"Bortolato","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2013.11.001_bb0055","doi-asserted-by":"crossref","first-page":"11642","DOI":"10.1073\/pnas.1220552110","article-title":"Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate","volume":"110","author":"Buchmayer","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.11.001_bb0060","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/appi.ajp.2011.11010052","article-title":"Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features","volume":"168","author":"Curley","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-012-2921-8","article-title":"Serotonin\u2013glutamate and serotonin\u2013dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins","volume":"225","author":"de Bartolomeis","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.nbd.2013.11.001_bb0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.148.2.224","article-title":"Drug abuse in schizophrenic patients: clinical correlates and reasons for use","volume":"148","author":"Dixon","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00428688","article-title":"Effects of delta9-THC, LSD-25 and scopolamine on continuous, spontaneous alternation in the Y-maze","volume":"32","author":"Drew","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.nbd.2013.11.001_bb0080","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archpsyc.65.7.772","article-title":"Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia","volume":"65","author":"Eggan","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0085","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.neuroscience.2010.06.011","article-title":"Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex","volume":"169","author":"Eggan","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2013.11.001_bb0090","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/npp.2010.75","article-title":"Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: comparison of schizophrenia and major depressive disorder","volume":"35","author":"Eggan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2013.11.001_bb0095","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuron.2009.05.026","article-title":"Amygdala inhibitory circuits and the control of fear memory","volume":"62","author":"Ehrlich","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2013.11.001_bb0100","doi-asserted-by":"crossref","first-page":"e08","DOI":"10.4088\/JCP.12012tx2c","article-title":"Does using marijuana increase the risk for developing schizophrenia?","volume":"74","author":"Evins","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0105","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/jpet.105.091074","article-title":"A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2\/3 receptor agonist in mouse models predictive of antipsychotic activity","volume":"315","author":"Galici","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2013.11.001_bb0110","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2174\/138161208785740117","article-title":"Mechanisms of control of neuron survival by the endocannabinoid system","volume":"14","author":"Galve-Roperh","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2013.11.001_bb0115","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1523\/JNEUROSCI.1223-09.2009","article-title":"Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance","volume":"29","author":"Ganon-Elazar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0120","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/mp.2010.1","article-title":"Novel animal models for studying complex brain disorders: BAC-driven miRNA-mediated in vivo silencing of gene expression","volume":"15","author":"Garbett","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0521s31","article-title":"Modification of bacterial artificial chromosomes (BACs) and preparation of intact BAC DNA for generation of transgenic mice","author":"Gong","year":"2005","journal-title":"Curr. Protoc. Neurosci"},{"key":"10.1016\/j.nbd.2013.11.001_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10550490490435795","article-title":"Substance-abusing schizophrenics: do they self-medicate?","volume":"13","author":"Goswami","year":"2004","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.nbd.2013.11.001_bb0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0140","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.febslet.2005.08.079","article-title":"Dicing and slicing: the core machinery of the RNA interference pathway","volume":"579","author":"Hammond","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2013.11.001_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tips.2006.12.004","article-title":"The emerging functions of endocannabinoid signaling during CNS development","volume":"28","author":"Harkany","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0150","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1523\/JNEUROSCI.23-15-06315.2003","article-title":"Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia","volume":"23","author":"Hashimoto","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0155","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.38267.664086.63","article-title":"Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people","volume":"330","author":"Henquet","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.nbd.2013.11.001_bb0160","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0361-9230(87)90047-5","article-title":"Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin","volume":"19","author":"Hernandez","year":"1987","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2013.11.001_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2011.11.020","article-title":"Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence","volume":"204","author":"Hillard","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2013.11.001_bb0170","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm0509-488","article-title":"Breaking the gene barrier in schizophrenia","volume":"15","author":"Horvath","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2013.11.001_bb0175","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.95.26.15718","article-title":"A decrease of reelin expression as a putative vulnerability factor in schizophrenia","volume":"95","author":"Impagnatiello","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.11.001_bb0180","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1176\/ajp.154.6.726","article-title":"A neurobiological basis of social attachment","volume":"154","author":"Insel","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0924-977X(95)00027-M","article-title":"The role of serotonin in schizophrenia","volume":"5","author":"Iqbal","year":"1995","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2013.11.001_bb0190","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","article-title":"Serotonin\u2013dopamine interaction and its relevance to schizophrenia","volume":"153","author":"Kapur","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0195","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4522(00)00286-4","article-title":"GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus","volume":"100","author":"Katona","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2013.11.001_bb0200","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","volume":"21","author":"Katona","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0210","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1523\/JNEUROSCI.0309-06.2006","article-title":"Molecular composition of the endocannabinoid system at glutamatergic synapses","volume":"26","author":"Katona","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: a reconsideration and recent applications","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0220","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1371\/journal.pbio.0020078","article-title":"N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux","volume":"2","author":"Khoshbouei","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.nbd.2013.11.001_bb0225","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/schbul\/sbj053","article-title":"The NIMH-MATRICS consensus statement on negative symptoms","volume":"32","author":"Kirkpatrick","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.nbd.2013.11.001_bb0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1126\/science.1149381","article-title":"Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations","volume":"321","author":"Klausberger","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.nbd.2013.11.001_bb0235","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0240","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/gbb.12045","article-title":"CB1 receptor signaling regulates social anxiety and memory","volume":"12","author":"Litvin","year":"2013","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2013.11.001_bb0245","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0250","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","article-title":"Involvement of CB1 cannabinoid receptors in emotional behaviour","volume":"159","author":"Martin","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2013.11.001_bb0255","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2011.09.020","article-title":"A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia","volume":"133","author":"Matheson","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.nbd.2013.11.001_bb0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.biopsych.2006.02.003","article-title":"Critical appraisal of DNA microarrays in psychiatric genomics","volume":"60","author":"Mirnics","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0265","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0163-1047(81)91677-0","article-title":"Olfactory regulation of responsiveness to novelty in mice","volume":"33","author":"Misslin","year":"1981","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.nbd.2013.11.001_bb0270","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pbio.0050269","article-title":"Genetic dissection of behavioural and autonomic effects of delta(9)-tetrahydrocannabinol in mice","volume":"5","author":"Monory","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.nbd.2013.11.001_bb0275","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S0033291709005522","article-title":"The acute effects of synthetic intravenous delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning","volume":"39","author":"Morrison","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.nbd.2013.11.001_bb0285","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/schbul\/16.1.31","article-title":"Prevalence of substance abuse in schizophrenia: demographic and clinical correlates","volume":"16","author":"Mueser","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.nbd.2013.11.001_bb0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0920-9964(91)90044-R","article-title":"Prevalence and stability of social skill deficits in schizophrenia","volume":"5","author":"Mueser","year":"1991","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.nbd.2013.11.001_bb0290","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1586\/14737175.8.7.1037","article-title":"Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia","volume":"8","author":"Muller-Vahl","year":"2008","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.nbd.2013.11.001_bb0295","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00213-010-2029-y","article-title":"Presynaptic control of serotonin on striatal dopamine function","volume":"213","author":"Navailles","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.nbd.2013.11.001_bb0300","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.2174\/138161212802884609","article-title":"Gene-environment interactions underlying the effect of cannabis in first episode psychosis","volume":"18","author":"Pelayo-Teran","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2013.11.001_bb0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbr.2013.03.025","article-title":"Electrolytic lesion of the nucleus incertus retards extinction of auditory conditioned fear","volume":"247","author":"Pereira","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2013.11.001_bb0310","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/(SICI)1097-4547(19980201)51:3<391::AID-JNR12>3.0.CO;2-A","article-title":"Immunohistochemical localization of the neural cannabinoid receptor in rat brain","volume":"51","author":"Pettit","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2013.11.001_bb0315","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1037\/0735-7044.106.2.274","article-title":"Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning","volume":"106","author":"Phillips","year":"1992","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0320","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2013.11.001_bb0325","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/454589a","article-title":"Behavioural neuroscience: the circuit of fear","volume":"454","author":"Sah","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2013.11.001_bb0330","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nbd.2012.11.020","article-title":"Endocannabinoid system: potential novel targets for treatment of schizophrenia","volume":"53","author":"Saito","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.11.001_bb0335","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000336731","article-title":"Modeling interneuron dysfunction in schizophrenia","volume":"34","author":"Schmidt","year":"2012","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0340","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/npp.2013.81","article-title":"Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid cb1 receptors: implications for schizophrenia","volume":"38","author":"Seillier","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2013.11.001_bb0345","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1101\/lm.614807","article-title":"Genetic background differences and nonassociative effects in mouse trace fear conditioning","volume":"14","author":"Smith","year":"2007","journal-title":"Learn. Mem."},{"key":"10.1016\/j.nbd.2013.11.001_bb0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2012.09.023","article-title":"Dopaminergic modulation of synaptic transmission in cortex and striatum","volume":"76","author":"Tritsch","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2013.11.001_bb0355","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2013.11.001_bb0360","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.mp.4001029","article-title":"CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia","volume":"7","author":"Ujike","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0365","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwf043","article-title":"Cannabis use and psychosis: a longitudinal population-based study","volume":"156","author":"van Os","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.nbd.2013.11.001_bb0370","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1176\/appi.ajp.161.3.501","article-title":"Cannabis use and age at onset of schizophrenia","volume":"161","author":"Veen","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0375","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1570159052773396","article-title":"GABA targets for the treatment of cognitive dysfunction in schizophrenia","volume":"3","author":"Volk","year":"2005","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2013.11.001_bb0385","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.schres.2007.03.010","article-title":"Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction","volume":"93","author":"Waltz","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.nbd.2013.11.001_bb0380","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.biopsych.2006.09.042","article-title":"Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal\u2013cortical dysfunction","volume":"62","author":"Waltz","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2013.11.001_bb0390","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-biophys-083012-130404","article-title":"Molecular mechanisms of RNA interference","volume":"42","author":"Wilson","year":"2013","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.nbd.2013.11.001_bb0395","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(01)00372-5","article-title":"Presynaptic specificity of endocannabinoid signaling in the hippocampus","volume":"31","author":"Wilson","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2013.11.001_bb0400","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.1073\/pnas.0908584106","article-title":"Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans","volume":"106","author":"Xu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.11.001_bb0405","first-page":"24","article-title":"Simple behavioral assessment of mouse olfaction","author":"Yang","year":"2009","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0410","first-page":"26","article-title":"Automated three-chambered social approach task for mice","author":"Yang","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.nbd.2013.11.001_bb0415","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","article-title":"Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice","volume":"96","author":"Zimmer","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113003057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113003057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:10:16Z","timestamp":1760850616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996113003057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":83,"alternative-id":["S0969996113003057"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2013.11.001","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of cannabinoid 1 receptor expressing interneurons in behavior","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2013.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}